North America Chronic Idiopathic Constipation Drug Market Forecast 2017-2025

Friday, July 21, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, July 20, 2017 /PRNewswire/ -- KEY FINDINGS The North America Chronic Idiopathic Constipation Drug Market

is expected to grow at a CAGR of 7.20%. The market value is expected to rise from $818 million in 2016 to $1527.50 million by 2025. The changing modern dietary habits, chances of cancer or other
systematic disease leading to CIC and the growing increasing elderly population are some of the factors driving the market. Download the full report: https://www.reportbuyer.com/product/5012011/MARKET INSIGHTS The North America chronic idiopathic constipation drug market is segmented on the basis of drug types and on the basis of the type of prescriptions. The drug type can be further divided into lubiprostone and linaclotide, with the former being a more popular drug in the market. The prescription drug market can be further segmented into over the counter drugs and prescribed drugs. Continuous government initiatives and the already flourishing healthcare and medical industry in countries such as the United States and Canada are benefiting the CIC market growth in this region. COMPETITIVE INSIGHTS Some of the major players in the market include Chugai Pharmaceutical, Allergens, Synergy Pharmaceuticals, Ferring International Center S.A., Pfizer, GlaxoSmithKline, Roche Holding Ag, Merck Sharp & Dohme, Sanofi, Bayer Ag, Eli Lilly And Company, Sucampo Pharmaceuticals Inc, Salix Pharmaceuticals Ltd, Ironwood Pharmaceuticals Inc, Daiichi Sankyo Co Ltd, Valeant Pharmaceuticals International, Cosmo Pharmaceuticals Sa, Theravance Biopharma Inc and Progenics Pharmaceuticals Inc. Download the full report: https://www.reportbuyer.com/product/5012011/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com  Tel: +44 208 816 85 48 Website: www.reportbuyer.com

View original content:http://www.prnewswire.com/news-releases/north-america-chronic-idiopathic-constipation-drug-market-forecast-2017-2025-300491807.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook